Cargando…
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
BACKGROUND: The year 2020 witnessed a largely unprecedented pandemic of coronavirus disease (COVID-19), caused by SARS COV-2. Many people with COVID-19 have comorbidities, including diabetes, hypertension and cardiovascular diseases, which are significantly associated with worse outcomes. Moreover,...
Autores principales: | Pathan, Faruque, Selim, Shahjada, Fariduddin, Md, Rahman, Md Hafizur, Ashrafuzzaman, S M, Afsana, Faria, Qureshi, Nazmul Kabir, Hossain, Tanjina, Saifuddin, M, Kamrul-Hasan, A B, Mir, Ahmed Salam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140905/ https://www.ncbi.nlm.nih.gov/pubmed/34040407 http://dx.doi.org/10.2147/DMSO.S293688 |
Ejemplares similares
-
Endocrine research in Bangladesh: Evolution and current trend
por: Kamrul-Hasan, A. B. M., et al.
Publicado: (2022) -
Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh
por: Pathan, M D Faruque, et al.
Publicado: (2022) -
Economic Burden of Severe Hypoglycemia Among Patients With Diabetes Mellitus
por: Ahammed, Afsar, et al.
Publicado: (2022) -
Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
por: Kalra, Sanjay, et al.
Publicado: (2017) -
The Burden of Severe Hypoglycemia on Quality of Life among Diabetes Mellitus Patients in a Tertiary Level Hospital of Bangladesh
por: Ahammed, Afsar, et al.
Publicado: (2018)